For instance, different types of TP53 mutations have been described in the early preneoplastic stages of gastric, colorectal, and lung cancers [83,84,85,86], strongly suggesting that TP53 is altered in the initial stages of cancer probably induced by early and persistent inflammatory processes. This evidence concerns the gene TP53 and cancer.